Merrimack Pharmaceuticals
MACK
#8754
Rank
ยฃ0.17 B
Marketcap
ยฃ11.55
Share price
0.00%
Change (1 day)
2.39%
Change (1 year)

Earnings for Merrimack Pharmaceuticals (MACK)

Earnings in 2024 (TTM): -ยฃ1.8 Million

According to Merrimack Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -ยฃ1.67 Million a decrease over its 2022 earnings that were of -ยฃ1.66 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Merrimack Pharmaceuticals from 2010 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -ยฃ1.8 Million8.21%
2023 -ยฃ1.67 Million0.09%
2022 -ยฃ1.66 Million-16.9%
2021 -ยฃ2 Million-49.89%
2020 -ยฃ3.99 Million-75.39%
2019 -ยฃ16.19 Million-68.58%
2018 -ยฃ51.52 Million-19.4%
2017 -ยฃ63.92 Million-36.46%
2016 -ยฃ0.11 Billion2.54%
2015 -ยฃ98.11 Million96.78%
2014 -ยฃ49.86 Million-45.44%
2013 -ยฃ91.39 Million
2010 -ยฃ35.44 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sanofi
SNY
ยฃ5.94 B-344,855.64%๐Ÿ‡ซ๐Ÿ‡ท France
Geron
GERN
-ยฃ14.53 Million 742.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Clovis Oncology
CLVS
-ยฃ0.17 Billion 9,523.90%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
-ยฃ22.17 Million 1,185.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-ยฃ12.61 Million 631.30%๐Ÿ‡บ๐Ÿ‡ธ USA